APL-2, a Complement C3 Inhibitor, May Potentially Reduce Both Intravascular and Extravascular Hemolysis in Patients with Paroxysmal Nocturnal Hemoglobinuria
Molecular Immunology(2017)
AI 理解论文
溯源树
样例

生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
Molecular Immunology(2017)